B Trademark

Trademark Overview


On Wednesday, June 22, 2022, a trademark application was filed for B with the United States Patent and Trademark Office. The USPTO has given the B trademark a serial number of 97470839. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, August 8, 2024. This trademark is owned by BridgeBio Pharma, Inc.. The B trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Pharmaceutical research and development services
b

General Information


Serial Number97470839
Word MarkB
Filing DateWednesday, June 22, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, August 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Pseudo MarkBRIDGEBIO; BRIDGE BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 11, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBridgeBio Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Party NameBridgeBio Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events


Event DateEvent Description
Sunday, December 11, 2022ASSIGNED TO EXAMINER
Saturday, June 25, 2022NEW APPLICATION ENTERED
Monday, July 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 12, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2023SOU EXTENSION 1 FILED
Friday, August 11, 2023SOU EXTENSION 1 GRANTED
Thursday, February 8, 2024SOU EXTENSION 2 GRANTED
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2024SOU EXTENSION 2 FILED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024SOU EXTENSION 3 FILED
Thursday, August 8, 2024SOU EXTENSION 3 GRANTED